Baptist Health Breaks Ground on New Home of Kenneth C Griffin Neuroscience Institute

• by

• October 12, 2026

The association between MGMT expression and outcome in H3 G34-mutant diffuse hemispheric glioma is robust to adjustment for pre-analytic and technical variables

• by Qunyu Zhang, Dana Tlais, Tong Lin, Xiaoyu Li, Arzu Onar-Thomas, Jason Chiang

• October 14, 2026

AI may predict focal GBM recurrence

Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.

• by Andrea Surnit

• October 15, 2026

• 4 min

Cerebral hypoperfusion in neurocritical care. Ready for a TCD-guided therapy

• by Anselmo Caricato, Camilla Gelormini, Luca Pisapia, Angela Scavone, Melania Cesarano, Valentina Giammatteo

• October 5, 2026